Positron emission tomography predicts survival in malignant pleural mesothelioma
- 31 October 2006
- journal article
- Published by Elsevier in The Journal of Thoracic and Cardiovascular Surgery
- Vol. 132 (4) , 763-768
- https://doi.org/10.1016/j.jtcvs.2006.03.068
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Positron emission tomography defines metastatic disease but not locoregional disease in patients with malignant pleural mesotheliomaThe Journal of Thoracic and Cardiovascular Surgery, 2003
- Positron emission tomography with f18-fluorodeoxyglucose in the staging and preoperative evaluation of malignant pleural mesotheliomaThe Journal of Thoracic and Cardiovascular Surgery, 2000
- 18-FDG positron emission tomography in the evaluation of malignant pleural diseases – a pilot studyEuropean Journal of Cardio-Thoracic Surgery, 2000
- Important prognostic factors in patients with malignant pleural mesothelioma, managed surgicallyThe Annals of Thoracic Surgery, 1999
- Staging of malignant pleural mesothelioma: comparison of CT and MR imaging.American Journal of Roentgenology, 1999
- Resection margins, extrapleural nodal status, and cell type determine postoperative long-term survival in trimodality therapy of malignant pleural mesothelioma: Results in 183 patientsThe Journal of Thoracic and Cardiovascular Surgery, 1999
- Metabolic Imaging of Malignant Pleural Mesothelioma With Fluorodeoxyglucose Positron Emission TomographyChest, 1998
- Malignant pleural mesothelioma: value of CT and MR imaging in predicting resectability.American Journal of Roentgenology, 1992
- Maximally Selected Chi Square StatisticsPublished by JSTOR ,1982